CONNECTs
Our programmes
- See All
- Podcast
- Experts knowledge share
- E-learning
- Video
- Publication
- Other
Endocrinology Pediatrics Oncology
Key Publication Snapshot 5: TRK xDFG mutations trigger a sensitivity switch from type I to II kinase inhibitors
Experts
Dr Luca Toschi-
Downloadable
Resources -
5 MIN
-
Sep 2021
Downloadable 
5 MIN
Sep 2021 
Oncology Pediatrics Endocrinology
Learn about the patient journey through diagnosis and treatment of NTRK fusion positive cancer
Experts
Prof. Ulrik Lassen, Assoc. Prof. Caterina Marchiò-
5 MIN
-
Sep 2021
Oncology Endocrinology
Key Publication Snapshot – Detection of NTRK 1/3 rearrangements in Papillary Thyroid Carcinoma
Experts
Prof. Fernando López-Ríos, MD, PhD-
Downloadable
Resources -
5 MIN
-
Sep 2021
-
Downloadable
Resources -
5 MIN
-
Sep 2021
-
Downloadable
Resources -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Key Publication Snapshot 3 – Characterisation of adverse events caused by TRK inhibitor therapy
Experts
Prof. Ezra Cohen-
Downloadable
Resources -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Current opinions on how to identify and treat NTRK fusion positive cancer
Experts
Prof. David Hong, Prof. Ezra Cohen, Prof. Frédérique Penault-Llorca-
Downloadable
Resources -
5 MIN
-
Sep 2021
Endocrinology Pediatrics Oncology
Key Publication Snapshot 2 – Identifying patients with NTRK fusion cancer
Experts
Prof. Fernando López-Ríos, MD, PhD-
Downloadable
Resources -
5 MIN
-
Sep 2021
Pediatrics Oncology Endocrinology
Highlights BY NTRK CONNECT – Key NTRK fusion abstracts from USCAP, ELCC and AACR 2021
Experts
Dr Fernando Santini-
Downloadable
Resources -
5 MIN
-
Sep 2021
Pediatrics Oncology Endocrinology
NTRK CONNECT Update from ESMO 2019
Experts
Assoc. Prof. Caterina Marchiò-
Downloadable
Resources -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Key Publication Snapshot 1 – Larotrectinib and Entrectinib efficacy and safety profile in solid tumours
Experts
Prof. Andrea Sartore-Bianchi-
Downloadable
Resources -
5 MIN
-
Sep 2021
Oncology Endocrinology Pediatrics
Highlights BY NTRK CONNECT – Key NTRK fusion abstracts from ASCO and WCGIC 2021
Experts
Prof. Andrea Sartore-Bianchi-
Downloadable
Resources -
5 MIN
-
Sep 2021
Pediatrics Oncology Endocrinology
NTRK gene fusions, TRK inhibitors and testing approaches BluePrint
Experts
Prof. Andrea Sartore-Bianchi, Prof. Fernando López-Ríos, MD, PhD, Assoc. Prof. Gerald Prager-
Downloadable
Resources -
5 MIN
-
Sep 2021
Podcast
Endocrinology Oncology
Optimising VEGFR-TKIs (MKIs) in Differentiated Thyroid Cancer
Experts
Dr Jaume Capdevila, Dr Rachel van Leeuwaarde-
MIN
-
Oct 2021
Oncology
PARP inhibition and DNA Damage Response (DDR)
This comprehensive resource looks at PARP inhibition and DDR as therapeutic targets across multiple tumour types
Experts
Prof. Simon Boulton, Dr Violeta Serra, Dr Judith Balmaña, Prof. Charlie Gourley-
30 MIN
-
Oct 2021
Oncology Rare diseases Pediatrics
Targeting NTRK gene fusions
Experts
Prof. Fernando López-Ríos, MD, PhD, Prof. Andrea Sartore-Bianchi, Assoc. Prof. Gerald Prager, Dr Jaclyn Hechtman-
30 MIN
-
Dec 2021
Rare diseases Oncology
TRK fusion-positive cancer highlights from ASCO 2022
Experts
Prof. David Hong-
Downloadable
Resources -
5 MIN
-
Jun 2022
Interactive e-learning
Module
1
of 3
Oncology
Patient case reports: from diagnosis to treatment of TRK-fusion positive cancer
Assoc. Prof. Caterina Marchio: A lung cancer case
Experts
Dr Philipp Ivanyi, Assoc. Prof. Caterina Marchiò, Prof. David Hong-
Downloadable
Resources -
15 MIN
-
Aug 2022
Conference update
TRK fusion-positive cancer: new ESMO OncologyPRO learning resource
Experts
Prof. Ezra Cohen, Prof. Frédérique Penault-Llorca, Prof. Silvia Stacchiotti, Prof. Andrea Sartore-Bianchi, Prof. Fernando López-Ríos, MD, PhD, Prof. Christian Rolfo-
30 MIN
-
Aug 2022
Oncology
COR2ED at ESMO 2022
We celebrate our 10-year anniversary at the COR2ED booth during ESMO 2022. In 10 years, 500,000 healthcare professionals have trusted our educational programmes.
-
2 MIN
-
Sep 2022
Oncology
Update From ESMO 2022 Presidential Sessions
COR2ED brings you an update on a selection of late-breaking abstracts presented in the Presidential Symposia at ESMO 2022.
Experts
Dr Thomas Winder, Dr Ray Manneh Kopp, Dr Alfredo Addeo-
10 MIN
-
Sep 2022
-
Downloadable
Resources -
5 MIN
-
Sep 2022
Episode
1
of 3
Oncology
TRK fusion-positive cancer poster tour at ESMO 2022
Poster 1: Dufresne A. et al (ESMO 2022)
Experts
Prof. David Hong-
1 MIN
-
Oct 2022
Oncology
Current perspectives on TRK fusion-positive thyroid cancers
Clinical summary video and slides
Experts
Prof. Ezra Cohen-
Downloadable
Resources -
5 MIN
-
Dec 2022
Video
Oncology
Actionable fusions in solid tumours
An overview of gene fusions, gold standard detection methods and treatment implications
Experts
Prof. Fernando López-Ríos, MD, PhD-
Downloadable
Resources -
3 MIN
-
Dec 2023
Video
Oncology Patient Support
The patient perspective: Living with NSCLC driven by a rare alteration
What to know, what to expect, and where to find support
Endorsed by
-
5 MIN
-
Apr 2025